New diabetes clinical trial: Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Published on: November 12, 2025 at 11:00PM
Conditions: Diabetes (Insulin-requiring, Type 1 or Type 2)
Interventions: Device: NMX8; Device: 780G
Sponsors: Medtronic Diabetes
Not yet recruiting
https://ift.tt/Krkiaev